Clinical Trial

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Study acronym: DAPTO-SNAP
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream infection which will directly compare the two most commonly used therapies, vancomycin and daptomycin. This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119)
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2024-10-09; most recent amendment 2026-07-16.
Status change: Not Yet Recruiting → Recruiting 2024-11-15
Trial Details
NCT Number NCT06637332
Lead Sponsor Todd C. Lee MD MPH FIDSA
Collaborators: University of Melbourne, The Peter Doherty Institute for Infection and Immunity
Conditions Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection, Staphylococcus Aureus Endocarditis
Enrollment 300 participants
Start Date 2024-11-14
Primary Completion 2027-01 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-31